ProfileGDS4718 / 211996_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 91% 91% 90% 87% 91% 85% 84% 87% 85% 88% 83% 94% 89% 87% 83% 85% 79% 90% 83% 99% 89% 83% 86% 86% 90% 87% 88% 93% 90% 89% 82% 88% 91% 83% 89% 89% 91% 92% 89% 83% 83% 92% 88% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.4166191
GSM549102patient 115, normal, homogenized [OPG study]9.4128291
GSM549104patient 119, normal, homogenized [OPG study]9.2274290
GSM549108patient 138, normal, homogenized [OPG study]8.6104587
GSM549119patient 077, normal, homogenized [OPG study]9.4712591
GSM549133patient 032, cancer, homogenized [OPG study]8.5548785
GSM549139patient 042, cancer, homogenized [OPG study]8.3400484
GSM549099patient 107, normal, homogenized [OPG study]8.6251587
GSM549109patient 139, normal, homogenized [OPG study]8.4064385
GSM549110patient 046, normal, homogenized [OPG study]8.9353188
GSM549114patient 063, normal, homogenized [OPG study]8.3692483
GSM549122patient 082, normal, homogenized [OPG study]10.119994
GSM549134patient 033, cancer, homogenized [OPG study]8.9788389
GSM549136patient 036, cancer, homogenized [OPG study]8.8225787
GSM549140patient 044, cancer, homogenized [OPG study]8.274783
GSM549111patient 047, normal, homogenized [OPG study]8.5782185
GSM549113patient 057, normal, homogenized [OPG study]7.8177679
GSM549132patient 031, cancer, homogenized [OPG study]9.1661390
GSM549137patient 038, cancer, homogenized [OPG study]8.2759683
GSM549142patient 047, cancer, homogenized [OPG study]11.580499
GSM549100patient 110, normal, homogenized [OPG study]9.0130189
GSM549107patient 135, normal, homogenized [OPG study]8.2677883
GSM549115patient 068, normal, homogenized [OPG study]8.7128386
GSM549116patient 072, normal, homogenized [OPG study]8.6446186
GSM549120patient 078, normal, homogenized [OPG study]9.3055190
GSM549131patient 030, cancer, homogenized [OPG study]8.7660287
GSM549118patient 074, normal, homogenized [OPG study]8.9905688
GSM549129patient 027, cancer, homogenized [OPG study]9.6011793
GSM549123patient 088, normal, homogenized [OPG study]9.2927690
GSM549124patient 006, cancer, homogenized [OPG study]8.8300289
GSM549126patient 015, cancer, homogenized [OPG study]8.0424582
GSM549128patient 025, cancer, homogenized [OPG study]8.8568288
GSM549103patient 117, normal, homogenized [OPG study]9.2243591
GSM549117patient 073, normal, homogenized [OPG study]8.2924683
GSM549138patient 041, cancer, homogenized [OPG study]9.0101889
GSM549141patient 045, cancer, homogenized [OPG study]9.0904389
GSM549130patient 028, cancer, homogenized [OPG study]9.1886391
GSM549101patient 111, normal, homogenized [OPG study]9.4745192
GSM549105patient 128, normal, homogenized [OPG study]8.9243289
GSM549106patient 134, normal, homogenized [OPG study]8.4098583
GSM549112patient 048, normal, homogenized [OPG study]8.2186483
GSM549125patient 011, cancer, homogenized [OPG study]9.3948992
GSM549127patient 024, cancer, homogenized [OPG study]8.861688
GSM549135patient 035, cancer, homogenized [OPG study]8.3441583